SE (NASDAQ:ARGX – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst ...

Choreo LLC lifted its holdings in argenx SE (NASDAQ:ARGX – Free Report) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Shares increased as Vyvgart continued its launch in generalized myasthenia gravis and got off to a strong ... to be efficacious in three subsets of myositis (a group of rare autoimmune conditions ...

Overlap syndromes involving myasthenia gravis, myositis and myocarditis are recognised adverse effects of immune checkpoint inhibitors (ICI). We report a similar syndrome of myasthenia gravis and ...

Cemdisiran is under development for the treatment of complement-mediated diseases including paroxysmal nocturnal hemoglobinuria, myasthenia gravis, sporadic inclusion body myositis, geographic atrophy ...

Myositis-related Antibody Panel (including SRP ... of International Consensus Guidance for Management (5), the final diagnosis was MG with Myasthenia Gravis Foundation of America (MGFA) Type IIa ...

No other tumours are associated with myasthenia gravis. Myositis is a common paraneoplastic manifestation either in the form of polymyositis or dermatomyositis. In general, patients with ...

The positive predictive value (PPV) of myositis antibodies for diagnosing myositis and its related conditions differs by individual antibody type. Greater diagnostic accuracy is associated with ...